NPI Details
DR. Aditi Choudhry, M.D. is an internal medicine in Walnut Creek, CA with 21 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Aditi Choudhry, M.D. NPI is 1427218908. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
1220 ROSSMOOR PKWY
WALNUT CREEK, CA
ZIP 94595-501
Phone: (925) 947-3393
Fax: (925) 947-3396
The NPI 1427218908 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, fosaprepitant, 1 mg (HCPCS:J1453)
- Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
- Injection, pembrolizumab, 1 mg (HCPCS:J9271)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Injection, potassium chloride, per 2 meq (HCPCS:J3480)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
- Infusion, normal saline solution, 250 cc (HCPCS:J7050)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
- Infusion into a vein for hydration, each additional hour (HCPCS:96361)
- Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Ferritin (blood protein) level (HCPCS:82728)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Lactate dehydrogenase (enzyme) level (HCPCS:83615)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Injection, zoledronic acid, 1 mg (HCPCS:J3489)
- Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
- Application of on-body injector for under skin injection (HCPCS:96377)
- Magnesium level (HCPCS:83735)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Irrigation of implanted venous access drug delivery device (HCPCS:96523)
- Uric acid level, blood (HCPCS:84550)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
The enumeration date for this NPI number is 6/10/2008 and was last updated on 5/2/2013.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | MD155821 | OREGON | No |
| 2 | 207R00000X | Internal Medicine | | A115151 | CALIFORNIA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | P01149802 | OTHER | CALIFORNIA | RAILROAD MEDICARE |
| 2 | GE972Z | MEDICARE PIN | CALIFORNIA | |
